Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects (Q36522638)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 October 2012

Language	Label	Description	Also known as
English	Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects	scientific article published on 25 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects (English)

1 reference

Europe PubMed Central

14 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

J Michael Gaziano

1

1 reference

Europe PubMed Central

14 August 2017

Anthony H Cincotta

2

1 reference

Europe PubMed Central

14 August 2017

Aaron Vinik

3

1 reference

Europe PubMed Central

14 August 2017

Lawrence Blonde

4

1 reference

Europe PubMed Central

14 August 2017

Nancy Bohannon

5

1 reference

Europe PubMed Central

14 August 2017

Richard Scranton

6

1 reference

Europe PubMed Central

14 August 2017

publication date

25 October 2012

1 reference

Europe PubMed Central

14 August 2017

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

1 reference

Europe PubMed Central

14 August 2017

1

1 reference

Europe PubMed Central

14 August 2017

5

1 reference

Europe PubMed Central

14 August 2017

e002279

1 reference

Europe PubMed Central

14 August 2017

Autonomic imbalance: prophet of doom or scope for hope?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

The role of oxidative stress in the metabolic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Oxidative stress and endothelial dysfunction in hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

α2-adrenoceptor regulation of blood glucose homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Diurnal blood pressure variation and sympathetic activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

The relationship of plasma volume, sympathetic tone, and proinflammatory cytokines in young healthy nonpregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Nitric oxide and sympathetic nerve activity in the control of blood pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Standards of medical care in diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Sympathetic nervous system, diabetes, and hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Elevated heart rate as a predictor of increased cardiovascular morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

30 September 2017

Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

28 June 2018

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

28 June 2018

Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential Hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

28 June 2018

Heart rate and cardiovascular mortality: the Framingham Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

28 June 2018

Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

21 September 2018

Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

21 September 2018

Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

21 September 2018

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

21 September 2018

Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541616

21 October 2018

Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopaminergic modulation of pressor and hormonal responses in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retarding effect of lowered heart rate on coronary atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Catecholamine-induced lipolysis in obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart Rate Variability and Progression of Coronary Atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and classification of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state

1 reference

https://pubmed.ncbi.nlm.nih.gov/23316290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/JAHA.112.002279

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36522638&oldid=1636678231"